These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

385 related articles for article (PubMed ID: 26639769)

  • 1. Adsorption capacity of poly(ether imide) microparticles to uremic toxins.
    Tetali SD; Jankowski V; Luetzow K; Kratz K; Lendlein A; Jankowski J
    Clin Hemorheol Microcirc; 2016; 61(4):657-65. PubMed ID: 26639769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of extracts of poly(ether imide) microparticles on cytotoxicity, ROS generation and proinflammatory effects on human monocytic (THP-1) cells.
    Kumar RK; Basu S; Lemke HD; Jankowski J; Kratz K; Lendlein A; Tetali SD
    Clin Hemorheol Microcirc; 2016; 61(4):667-80. PubMed ID: 26639770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of nanoporous poly(ether imide) particle extracts on human aortic endothelial cells (HAECs).
    Kumar RK; Basu S; Lemke HD; Jankowski J; Kratz K; Lendlein A; Tetali SD
    Clin Hemorheol Microcirc; 2016; 64(4):931-940. PubMed ID: 27814290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Removal of protein-bound, hydrophobic uremic toxins by a combined fractionated plasma separation and adsorption technique.
    Brettschneider F; Tölle M; von der Giet M; Passlick-Deetjen J; Steppan S; Peter M; Jankowski V; Krause A; Kühne S; Zidek W; Jankowski J
    Artif Organs; 2013 Apr; 37(4):409-16. PubMed ID: 23330821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of Uremic Toxins from the Gut Microbiota on Bone: A Brief Look at Chronic Kidney Disease.
    Black AP; Cardozo LF; Mafra D
    Ther Apher Dial; 2015 Oct; 19(5):436-40. PubMed ID: 25944654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploring binding characteristics and the related competition of different protein-bound uremic toxins.
    Deltombe O; de Loor H; Glorieux G; Dhondt A; Van Biesen W; Meijers B; Eloot S
    Biochimie; 2017 Aug; 139():20-26. PubMed ID: 28528271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of Uremic Toxins for Kidney, Cardiovascular, and Bone Dysfunction.
    Fujii H; Goto S; Fukagawa M
    Toxins (Basel); 2018 May; 10(5):. PubMed ID: 29772660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impacts of Indoxyl Sulfate and p-Cresol Sulfate on Chronic Kidney Disease and Mitigating Effects of AST-120.
    Liu WC; Tomino Y; Lu KC
    Toxins (Basel); 2018 Sep; 10(9):. PubMed ID: 30208594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disposition and clinical implications of protein-bound uremic toxins.
    Jansen J; Jankowski J; Gajjala PR; Wetzels JFM; Masereeuw R
    Clin Sci (Lond); 2017 Jul; 131(14):1631-1647. PubMed ID: 28667064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The influence of different rewetting procedures on the thrombogenicity of nanoporous poly(ether imide) microparticles.
    Braune S; Bäckemo J; Lau S; Heuchel M; Kratz K; Jung F; Reinthaler M; Lendlein A
    Clin Hemorheol Microcirc; 2021; 77(4):367-380. PubMed ID: 33337356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. P
    Kamprom W; Tawonsawatruk T; Mas-Oodi S; Anansilp K; Rattanasompattikul M; Supokawej A
    Int J Med Sci; 2021; 18(3):744-755. PubMed ID: 33437209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tryptophan-Derived Uremic Toxins and Thrombosis in Chronic Kidney Disease.
    Addi T; Dou L; Burtey S
    Toxins (Basel); 2018 Oct; 10(10):. PubMed ID: 30322010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The aryl hydrocarbon receptor-activating effect of uremic toxins from tryptophan metabolism: a new concept to understand cardiovascular complications of chronic kidney disease.
    Sallée M; Dou L; Cerini C; Poitevin S; Brunet P; Burtey S
    Toxins (Basel); 2014 Mar; 6(3):934-49. PubMed ID: 24599232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting Uremic Toxins to Prevent Peripheral Vascular Complications in Chronic Kidney Disease.
    Wu CL; Tarng DC
    Toxins (Basel); 2020 Dec; 12(12):. PubMed ID: 33419312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of extracts prepared from modified porous poly(ether imide) microparticulate absorbers on cytotoxicity, macrophage differentiation and proinflammatory behavior of human monocytic (THP-1) cells.
    Kumar RK; Heuchel M; Kratz K; Lendlein A; Jankowski J; Tetali SD
    Clin Hemorheol Microcirc; 2018; 69(1-2):175-185. PubMed ID: 29630537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Future Avenues to Decrease Uremic Toxin Concentration.
    Vanholder RC; Eloot S; Glorieux GL
    Am J Kidney Dis; 2016 Apr; 67(4):664-76. PubMed ID: 26500179
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Bifunctional Adsorber Particle for the Removal of Hydrophobic Uremic Toxins from Whole Blood of Renal Failure Patients.
    Sternkopf M; Thoröe-Boveleth S; Beck T; Oleschko K; Erlenkötter A; Tschulena U; Steppan S; Speer T; Goettsch C; Jankowski V; Jankowski J; Noels H;
    Toxins (Basel); 2019 Jul; 11(7):. PubMed ID: 31277311
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The kidney and uremic toxin removal: glomerulus or tubule?
    Masereeuw R; Mutsaers HA; Toyohara T; Abe T; Jhawar S; Sweet DH; Lowenstein J
    Semin Nephrol; 2014 Mar; 34(2):191-208. PubMed ID: 24780473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expanded Haemodialysis as a Current Strategy to Remove Uremic Toxins.
    Ciceri P; Cozzolino M
    Toxins (Basel); 2021 May; 13(6):. PubMed ID: 34073439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aryl Hydrocarbon Receptor Activation in Chronic Kidney Disease: Role of Uremic Toxins.
    Brito JS; Borges NA; Esgalhado M; Magliano DC; Soulage CO; Mafra D
    Nephron; 2017; 137(1):1-7. PubMed ID: 28490014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.